Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 3;4(4):CD011890.
doi: 10.1002/14651858.CD011890.pub3.

Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews

William Gibson  1 , Benedict M Wand, Catherine Meads, Mark J Catley, Neil E O'Connell
Affiliations
Review

Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews

William Gibson et al. Cochrane Database Syst Rev. .

Abstract

Background: Chronic pain, considered to be pain lasting more than three months, is a common and often difficult to treat condition that can significantly impact upon function and quality of life. Treatment typically includes pharmacological and non-pharmacological approaches. Transcutaneous electrical nerve stimulation (TENS) is an adjunct non-pharmacological treatment commonly recommended by clinicians and often used by people with pain.

Objectives: To provide an overview of evidence from Cochrane Reviews of the effectiveness of TENS to reduce pain in adults with chronic pain (excluding headache or migraine).To provide an overview of evidence from Cochrane Reviews of the safety of TENS when used to reduce pain in adults with chronic pain (excluding headache or migraine).To identify possible sources of inconsistency in the approaches taken to evaluating the evidence related to TENS for chronic pain (excluding headache or migraine) in the Cochrane Library with a view to recommending strategies to improve consistency in methodology and reporting.To highlight areas of remaining uncertainty regarding the effectiveness of TENS for chronic pain (excluding headache or migraine) with a view to recommending strategies to reduce any uncertainty.

Methods: Search methodsWe searched the Cochrane Database of Systematic Reviews (CDSR), in the Cochrane Library, across all years up to Issue 11 of 12, 2018.Selection of reviewsTwo authors independently screened the results of the electronic search by title and abstract against inclusion/exclusion criteria. We included all Cochrane Reviews of randomised controlled trials (RCTs) assessing the effectiveness of TENS in people with chronic pain. We included reviews if they investigated the following: TENS versus sham; TENS versus usual care or no treatment/waiting list control; TENS plus active intervention versus active intervention alone; comparisons between different types of TENS; or TENS delivered using different stimulation parameters.Data extraction and analysisTwo authors independently extracted relevant data, assessed review quality using the AMSTAR checklist and applied GRADE judgements where required to individual reviews. Our primary outcomes included pain intensity and nature/incidence of adverse effects; our secondary outcomes included disability, health-related quality of life, analgesic medication use and participant global impression of change.

Main results: We included nine reviews investigating TENS use in people with defined chronic pain or in people with chronic conditions associated with ongoing pain. One review investigating TENS for phantom or stump-associated pain in people following amputation did not have any included studies. We therefore extracted data from eight reviews which represented 51 TENS-related RCTs representing 2895 TENS-comparison participants entered into the studies.The included reviews followed consistent methods and achieved overall high scores on the AMSTAR checklist. The evidence reported within each review was consistently rated as very low quality. Using review authors' assessment of risk of bias, there were significant methodological limitations in included studies; and for all reviews, sample sizes were consistently small (the majority of studies included fewer than 50 participants per group).Six of the eight reviews presented a narrative synthesis of included studies. Two reviews reported a pooled analysis.Primary and secondary outcomes One review reported a beneficial effect of TENS versus sham therapy at reducing pain intensity on a 0 to 10 scale (MD -1.58, 95% CI -2.08 to -1.09, P < 0.001, I² = 29%, P = 0.22, 5 studies, 207 participants). However the quality of the evidence was very low due to significant methodological limitations and imprecision. A second review investigating pain intensity performed a pooled analysis by combining studies that compared TENS to sham with studies that compared TENS to no intervention (SMD -0.85, 95% CI -1.36 to -0.34, P = 0.001, I² = 83%, P < 0.001). This pooled analysis was judged as offering very low quality evidence due to significant methodological limitations, large between-trial heterogeneity and imprecision. We considered the approach of combining sham and no intervention data to be problematic since we would predict these different comparisons may be estimating different true effects. All remaining reviews also reported pain intensity as an outcome measure; however the data were presented in narrative review form only.Due to methodological limitation and lack of useable data, we were unable to offer any meaningful report on the remaining primary outcome regarding nature/incidence of adverse effects, nor for the remaining secondary outcomes: disability, health-related quality of life, analgesic medication use and participant global impression of change for any comparisons.We found the included reviews had a number of inconsistencies when evaluating the evidence from TENS studies. Approaches to assessing risk of bias around the participant, personnel and outcome-assessor blinding were perhaps the most obvious area of difference across included reviews. We also found wide variability in terms of primary and secondary outcome measures, and inclusion/exclusion criteria for studies varied with respect to including studies which assessed immediate effects of single interventions.

Authors' conclusions: We found the methodological quality of the reviews was good, but quality of the evidence within them was very low. We were therefore unable to conclude with any confidence that, in people with chronic pain, TENS is harmful, or beneficial for pain control, disability, health-related quality of life, use of pain relieving medicines, or global impression of change. We make recommendations with respect to future TENS study designs which may meaningfully reduce the uncertainty relating to the effectiveness of this treatment in people with chronic pain.

PubMed Disclaimer

Conflict of interest statement

WG: none known.

BMW: none known.

CM: none known.

MJC: none known.

NEO: none known.

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

References

References to included reviews

Boldt 2014
    1. Boldt I, Eriks‐Hoogland I, Brinkhof MW, Bie R, Joggi D, Elm E. Non‐pharmacological interventions for chronic pain in people with spinal cord injury. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD009177.pub2] - DOI - PMC - PubMed
Brosseau 2003
    1. Brosseau l, Yonge KA, Welch V, Marchand S, Judd M, Wells GA, et al. Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD004377] - DOI - PMC - PubMed
Gibson 2017
    1. Gibson W, Wand BM, O'Connell NE. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2017, Issue 9. [DOI: 10.1002/14651858.CD011976.pub2] - DOI - PMC - PubMed
Hurlow 2012
    1. Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electrical nerve stimulation (TENS) for cancer pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD006276.pub3] - DOI - PMC - PubMed
Johnson 2015
    1. Johnson MI, Mulvey MR, Bagnall AM. Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD007264.pub3] - DOI - PMC - PubMed
Johnson 2017
    1. Johnson MI, Claydon LS, Herbison GP, Jones G, Paley CA. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database of Systematic Reviews 2017, Issue 10. [DOI: 10.1002/14651858.CD012172.pub2] - DOI - PMC - PubMed
Khadilkar 2008
    1. Khadilkar A, Odebiyi DO, Brosseau L, Wells GA. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low back pain. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD003008.pub3] - DOI - PMC - PubMed
Kroeling 2013
    1. Kroeling P, Gross A, Graham N, Burnie SJ, Szeto G, Goldsmith CH, et al. Electrotherapy for neck pain. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD004251.pub5] - DOI - PMC - PubMed
Rutjes 2009
    1. Rutjes AW, Nűesch E, Sterchi R, Kalichman L, Hendriks E, Osiri M, et al. Transcutaneous electrical nerve stimulation for osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD002823.pub2] - DOI - PMC - PubMed

Additional references

Al‐Smadi 2003
    1. Al‐Smadi J, Warke K, Wilson I, Cramp AF, Noble G, Walsh DM. A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis. Clinical Rehabilitation 2003;17(7):742‐9. - PubMed
APTA 2001
    1. American Physical Therapy Association. Guide to physical therapist practice. Second Edition. Physical Therapy 2001;81(1):9‐746. - PubMed
Ballegaard 1985
    1. Ballegaard S, Christophersen SJ, Dawids SG, Hesse J, Olsen NV. Acupuncture and transcutaneous electric nerve stimulation in the treatment of pain associated with chronic pancreatitis. Scandinavian Journal of Gastroenterology 1985;20(10):1249‐54. - PubMed
Bennett 2011
    1. Bennett MI, Hughes N, Johnson MI. Methodological quality in randomised controlled trials of transcutaneous electric nerve stimulation for pain: Low fidelity may explain negative findings. Pain 2011;152(6):1226‐32. - PubMed
Bjordal 2003
    1. Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta‐analysis with assessment of optimal treatment parameters for postoperative pain. European Journal of Pain 2003;7(2):181‐8. - PubMed
Boutron 2017
    1. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, Consort NPT Group. CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Annals of Internal Medicine 2017;167(1):40‐7. - PubMed
Brown 2007
    1. Brown L, Tabasam G, Bjordal JM, Johnson MI. An investigation into the effect of electrode placement of transcutaneous electrical nerve stimulation (TENS) on experimentally induced ischemic pain in healthy human participants. Clinical Journal of Pain 2007;23(9):735‐43. - PubMed
Buchmuller 2012
    1. Buchmuller A, Navez M, Milletre‐Bernardin M, Pouplin S, Presles E, Lantéri‐Minet M, et al. Value of TENS for relief of chronic low back pain with or without radicular pain. European Journal of Pain 2012;16(5):656‐65. - PubMed
Busse 2015
    1. Busse JW, Bartlett SJ, Dougados M, Johnston BC, Guyatt GH, Kirwan JR, et al. Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop. Journal of Rheumatology 2015 May 15 [Epub ahead of print]. - PubMed
Calvino 2006
    1. Calvino B, Grilo RM. Central pain control. Joint, Bone, Spine 2006;73(1):10‐6. - PubMed
Chesterton 2003
    1. Chesterton LS, Foster NE, Wright CC, Baxter GD, Barlas P. Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects. Pain 2003;106(1‐2):73‐80. - PubMed
Dailey 2013
    1. Dailey DL, Rakel BA, Vance CG, Liebano RE, Amrit AS, Bush HM, et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain 2013;154(11):2554‐62. - PMC - PubMed
Dechartres 2013
    1. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta epidemiological study. BMJ 2013;346:f2304. [DOI: 10.1136/bmj.f2304] - DOI - PMC - PubMed
DeSantana 2009
    1. DeSantana JM, Silva LF, Resende MA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience 2009;163(4):1233‐41. - PMC - PubMed
Dworkin 2008
    1. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105‐21. - PubMed
Gaskin 2012
    1. Gaskin DJ, Richard P. The economic costs of pain in the United States. Journal of Pain 2012;13(8):715‐24. - PubMed
Gebhart 2004
    1. Gebhart GF. Descending modulation of pain. Neuroscience and Biobehavioral Reviews 2004;27(8):729‐37. - PubMed
Gustavsson 2012
    1. Gustavsson J, Bjorkman J, Ljungcrantz C, Rhodin A, Rivano‐Fischer M, Sjolund KF, et al. Socio‐economic burden of patients with a diagnosis related to chronic pain ‐ register data of 840,000 Swedish patients. European Journal of Pain 2012;16(2):289‐99. - PubMed
Guyatt 2008
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924‐6. - PMC - PubMed
Guyatt 2011
    1. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence‐‐imprecision. Journal of Clinical Epidemiology 2011;64(12):1283‐93. - PubMed
Higgins 2008
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley & Sons, 2008.
Higgins 2011
    1. Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Avalilable from handbook.cochrane.org.
Hoffmann 2014
    1. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687. [DOI: 10.1136/bmj.g1687] - DOI - PubMed
Jadad 1996
    1. Jadad A, Moore A, Dea C. Assessing the quality of randomized trials: Is blinding necessary?. Controlled Clinical Trials 1996;17(1):1‐12. - PubMed
Johnson 2011
    1. Johnson MI, Bjordal JM. Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain. Expert Review of Neurotherapeutics 2011;11(5):735‐53. - PubMed
Kalra 2001
    1. Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). Journal of Pharmacology and Experimental Therapeutics 2001;298(1):257‐63. - PubMed
Kennedy 2014
    1. Kennedy J, Roll JM, Schraudner T, Murphy S, McPherson S. Prevalence of persistent pain in the U.S. adult population: new data from the 2010 national health interview survey. Journal of Pain 2014;15(10):979‐84. - PubMed
Köke 2004
    1. Köke AJ, Schouten JS, Lamerichs‐Geelen MJ, Lipsch JS, Kleef M, Patijn J. Pain reducing effect of three types of transcutaneous electrical nerve stimulation in patients with chronic pain: a randomized crossover trial. Pain 2004;108(1‐2):36‐42. - PubMed
Leadley 2012
    1. Leadley RM, Armstrong N, Lee YC, Allen A, Kleijnen J. Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. Journal of Pain & Palliative Care Pharmacotherapy 2012;26(4):310‐25. - PubMed
Maeda 2007
    1. Maeda Y, Lisi TL, Vance CG, Sluka KA. Release of GABA and activation of GABA(A) in the spinal cord mediates the effects of TENS in rats. Brain Research 2007;1136(1):43‐50. - PMC - PubMed
Matsuo 2014
    1. Matsuo H, Uchida K, Nakajima H, Guerrero AR, Watanabe S, Takeura N, et al. Early transcutaneous electrical nerve stimulation reduces hyperalgesia and decreases activation of spinal glial cells in mice with neuropathic pain. Pain 2014;155(9):1888‐901. - PubMed
Melzack 1965
    1. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150(3699):971‐9. - PubMed
Moore 1997
    1. Moore SR, Shurman J. Combined neuromuscular electrical nerve stimulation and transcutaneous electrical nerve stimulation for treatment of chronic back pain: a double blind repeated measures comparison. Archives of Physical Medicine and Rehabilitation 1997;78(1):55‐60. - PubMed
Moore 2013a
    1. Moore A, Derry S, Eccleston C, Kalso E. Expect analgesic failure; pursue analgesic success. BMJ 2013;346(7911):f2690. - PubMed
Moore 2013b
    1. Moore RA, Straube S, Aldington D. Pain measures and cut‐offs ‐ no worse than mild pain as a simple, universal outcome. Anaesthesia 2013;68(4):400‐12. [DOI: 10.1111/anae.12148] - DOI - PubMed
Moore 2014a
    1. Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice 2014;14(1):79‐94. - PubMed
Moore 2014b
    1. Moore RA, Cai N, Skljarevski V, Tölle TR. Duloxetine use in chronic painful conditions‐‐individual patient data responder analysis. European Journal of Pain 2014;18(1):67‐75. - PMC - PubMed
Moore 2014c
    1. Moore RA, Derry S, Simon LS, Emery P. Nonsteroidal anti‐inflammatory drugs, gastroprotection, and benefit‐risk. Pain Practice 2014;14(4):378‐95. - PMC - PubMed
Moran 2011
    1. Moran F, Leonard T, Hawthorne S, Hughes CM, McCrum‐Gardner E, Johnson MI, et al. Hypoalgesia in response to transcutaneous electrical nerve stimulation (TENS) depends on stimulation intensity. Journal of Pain 2011;12(8):929‐35. - PubMed
Nash 1990
    1. Nash TP, Williams JD, Machin D. TENS: Does the type of stimulus really matter?. Pain Clinic 1990;3:161‐8.
Nnoaham 2008
    1. Nnoaham KE, Kumbang J. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD003222.pub3] - DOI - PubMed
Nüesch 2010
    1. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta‐analyses of osteoarthritis trials: Meta‐epidemiological study. BMJ 2010;341(7766):241. - PMC - PubMed
Ossipov 2006
    1. Ossipov MH, Porecca F. Chronic pain: multiple manifestations, multiple mechanisms. Drug Discovery Today. Disease Mechanisms 2006;3(3):301‐3.
Rakel 2010
    1. Rakel B, Cooper N, Adams HJ, Messer BR, Frey Law LA, Dannen DR, et al. A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment. Journal of Pain 2010;11(3):230‐8. - PMC - PubMed
Reid 2011
    1. Reid KJ, Harker J, Bala MM, Truyers C, Kellen E, Bekkering GE, et al. Epidemiology of chronic non‐cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Current Medical Research and Opinion 2011;27(2):449‐62. - PubMed
Resende 2018
    1. Resende L, Meriwether E, Rampazo EP, Dailey D, Embree J, Deberg J, et al. Meta‐analysis of transcutaneous electrical nerve stimulation for relief of spinal pain. European Journal of Pain (London, England) 2018;22(4):663‐78. [DOI: 10.1102/ejp.1168] - DOI - PubMed
Sabino 2008
    1. Sabino GS, Santos CM, Francischi JN, Resende MA. Release of endogenous opioids following transcutaneous electric nerve stimulation in an experimental model of acute inflammatory pain. Journal of Pain 2008;9(2):157‐63. - PubMed
Santos 2013
    1. Santos CM, Francischi JN, Lima‐Paiva P, Sluka KA, Resende MA. Effect of transcutaneous electrical stimulation on nociception and edema induced by peripheral serotonin. International Journal of Neuroscience 2013;123(7):507‐15. - PubMed
Savović 2012
    1. Savović J, Jones H, Altman D, Harris R, Jűni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assessments 2012;16(35):1‐82. - PubMed
Shea 2007
    1. Shea BJ, Grimshaw JM, Wells G, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;7:10. - PMC - PubMed
Sluka 2003
    1. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. Journal of Pain 2003;4(3):109‐21. - PubMed
Sluka 2005
    1. Sluka KA, Vance CG, Lisi TL. High‐frequency, but not low‐frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn. Journal of Neurochemistry 2005;95(6):1794‐801. - PubMed
Sluka 2013
    1. Sluka KA, Bjordal JM, Marchand S, Rakel BA. What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature. Physical Therapy 2013;93(10):1397‐402. - PMC - PubMed
Somers 2009
    1. Somers DL, Clemente FR. Contralateral high or a combination of high‐ and low‐frequency transcutaneous electrical nerve stimulation reduces mechanical allodynia and alters dorsal horn neurotransmitter content in neuropathic rats. Journal of Pain 2009;10(2):221‐9. - PubMed
Treede 2015
    1. Treede RD, Rief W, Barke A, Aziz Q, Bennett M, Benoliel R, et al. A classification of chronic pain for ICD‐11. Pain 2015;156(6):1003‐7. - PMC - PubMed
Van Tulder 2003
    1. Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003;28(12):1290‐9. - PubMed
Vardeh 2016
    1. Vardeh D, Mannion R, Wolff CJ. Toward a mechanism‐based approach to pain diagnosis. Journal of Pain 2016;17(9):Suppl.2, T50‐T69. - PMC - PubMed
Wall 1967
    1. Wall PD, Sweet WH. Temporary abolition of pain in man. Science 1967;155(3758):108‐9. - PubMed
Warke 2006
    1. Warke K, Al‐Smadi J, Baxter D, Walsh DM, Lowe‐Strong A. Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized placebo‐controlled clinical trial. Clinical Journal of Pain 2006;22(9):812‐9. - PubMed
Wood 2008
    1. Wood L, Egger M, Gluud L, Schulz K, Jüni P, Altman D, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5. [DOI: 10.1136/bmj.39465.451748.AD] - DOI - PMC - PubMed

Publication types